Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
Clinical research on Xiedanxintai Tablet in treating angina caused by coronary heart disease
Hits 1810  Download times 1581  Received:February 11, 2008  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2008.02.04
Key Words   Xiedanxintai tablet;obstruction of QI in the chest;coronary artery disease
Author NameAffiliation
WU Chong-yang Department of Cardiac internal medicine, he Second Affiliated Hospital of Tianjin University of TCM, Tianjin 300150, China 
WU Yu 武汉联合药业有限责任公司 430070
 
SUN Lan-jun Department of Cardiac internal medicine, he Second Affiliated Hospital of Tianjin University of TCM, Tianjin 300150, China 
赵英强 Department of Cardiac internal medicine, he Second Affiliated Hospital of Tianjin University of TCM, Tianjin 300150, China 
李艳芬 天津中医药大学 300193 
Abstract
    [Objective] To observe the curative effect of Xiedanxintai tablet in treating angina pectoris caused by coronary heart disease(CHD and stagnation of QI and stasis of blood in TCM) and evaluate its safety. [Methods] According to the disease severity and the general condition of the patients they were divided randomly into several groups and a research method of doubleblind, doublemimesis, positive medicine control and multicenters was adopted. One hundred and forty five patients in treatment group was administrated with Xiedanxintai tablet. among them 72 cases were given with lowdose (three tablets, twice a day) and 73 cases with high dose (three tablets, three times a day). Seventy five patients were served as control giving orally complex salvia miltiorrhiza tablets (three tablets, three times a day). Four weeks later, the severity of angina pectoris, ECG, main symptoms of TCMetc. were collected and analyzed. [Results] There was no significant deference in improving Angina pectoris and the symptoms in TCM between Xiedanxintai tablet group and control. The effective rate in ECG improvement in the lowdose group was 66.67% and 68.49% in the high dose group. All of themwere more effective than that of the control group (49.33%, P<0.05). [Conclusion] Xiedanxintai tablet is effective at a certain degree in treatingangina pectoris caused by CHD and hasn't side and toxic action.

You are the 1618650 visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.